Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0644
D

Failure to Obtain Level II PASARR After New Schizoaffective Disorder Diagnosis

Chicago, Illinois Survey Completed on 01-09-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The deficiency involves the facility’s failure to obtain a Level II PASARR evaluation for a resident who was later identified as having a serious mental disorder. The resident’s Level I PASARR, completed at the hospital prior to admission on 7/17/2024, documented that no Level II was required because there was no known or suspected severe mental illness, intellectual disability, or related condition, and no mental health medications at that time. The resident was admitted on 7/25/2024. Subsequently, the admission record reflected a diagnosis of schizoaffective disorder with an onset date of 1/17/2025. A psychiatrist’s progress note dated 8/08/2024 documented a diagnosis of schizoaffective disorder, depressed type, with a past psychiatric history of schizoaffective disorder and historical use of lithium, and included an order to add Seroquel 50 mg at night. Interviews and record review showed that, despite the new or previously unreported diagnosis of schizoaffective disorder and the initiation of antipsychotic medication, the facility did not request or obtain a Level II PASARR for this resident. The nurse consultant confirmed that the resident did not have the schizoaffective diagnosis at the time of admission based on hospital and referral paperwork and acknowledged that the facility did not resubmit for a Level II PASARR. The admissions director stated that the initial Level I PASARR was done at the hospital and acknowledged that if a new schizoaffective diagnosis was made or missed during the first assessment, a new PASARR should have been obtained. The facility’s own PASARR policy, adopted 7/16/2025, states that when a new psychiatric diagnosis under mental disability or intellectual disability is added by a physician, or when the facility suspects such a condition, the facility will notify the appropriate state-designated authority by requesting a PASARR screening via AssessmentPro, which was not done in this case.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙